Oruka Therapeutics (ORKA) PT Raised to $200 at Guggenheim
Guggenheim analyst Yatin Suneja raised the price target on Oruka Therapeutics (NASDAQ: ORKA) to $200.00 (from $125.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
